Navigation Links
NZymeCeuticals Announces the Introduction of New Bulk Ingredient 'Platinum Nattokinase' (PN20K) to Dietary Supplement Industry
Date:9/8/2008

NZymeCeuticals, Inc., (d/b/a NZyme) a company established in 2002, will begin to market "Platinum Nattokinase" (PN20K) Sept. 2008. Dr. Ralph E. Holsworth, President of NZymeCeuticals, Inc., announced Friday the company will begin to market the new line of bulk powder enzyme ingredient, nattokinase as "PN20K" to North and South America.

Durango, CO (PRWEB) September 8, 2008 -- "PN20K" is a pro-fibrinolytic enzyme that is extracted from a particular type of fermented soybean (natto) and renown in the dietary supplement industry and medical field for its "blood clot busting" abilities. "The new line has been in development for the past two years in Japan and establishes the 'platinum' standard for nattokinase." "PN20K is patent protected and manufactured by an ISO 9000 certified Japanese manufacturer," says Dr. Holsworth. A number of Japanese researchers and Dr. Holsworth collaborated on specific characteristics of nattokinase, enhancing the specificity of nattokinase's ability to breakup "cross-linked" fibrin and increasing its stability in clinical settings. In addition, PN20K significantly improves the way blood flows and enhances human microcirculation, promising novel therapeutic modalities for hypertension, coronary artery disease, diabetes, cerebrovascular accidents and deep vein thrombosis.

Dr. Holsworth first introduced nattokinase to the United States in 2002. Since then, the ingredient has gained much attention largely due to its naturally occurring "blood clot busting" ability. During this time, Dr. Holsworth and Dr. Sumi (the discoverer of nattokinase) have met several times in Japan and the USA to discuss the therapeutic properties of the enzyme and its future medical use. Over the years, Drs. Holsworth and Sumi continue to collaborate on the studies and findings of nattokinase. Initial research indicates PN20K has the potential to significantly impact cardiovascular diseases because of its ability to change chemical and physical characteristics of blood, providing a "one-two punch." "We simply don't see these positive effects with typical pharmaceutical drugs," says Dr. Holsworth.

In Japan, the enzyme has an annual 15 billion yen market. Since its introduction to the U.S. market, bulk sales for the enzyme have experienced increased growth and demand. With different manufacturers of nattokinase from all over the world, the activity, stability and purity of the product varies significantly. NZymeCeuticals' bulk ingredients undergo third-party testing for quality assurance and quality control as well as to preserving the integrity of the new ingredient. Clinical research using PN20K as the therapeutic agent is well underway.

http://www.nzymeceuticals.com

###

Read the full story at http://www.prweb.com/releases/nattokinase/holsworth/prweb1294934.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services
2. Z Trim Holdings, Inc. Announces Private Placement Funding
3. The Risk Management and Patient Safety Institute Announces Agreement With Pioneering Health Care Simulation Organization, PSO One
4. Cogdell Spencer Announces First Synergy Project in Pensacola, Florida
5. Conde Nast Media Group Announces Performance of Just Stand Up to be Fed Live from the Stage at FASHION ROCKS to ABC, CBS and NBCs Simultaneous Broadcast of Stand Up To Cancer Nationwide Fund-Raising Event On September 5th
6. LIFE Foundation Announces 2008 realLIFEstories Award Recipients to Illustrate Benefits of Life and Disability Insurance
7. Elbit Imaging Ltd. Announces Second Quarter Results for 2008
8. Custom Briefings Announces Launch of Endocrine Daily Briefing
9. Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss
10. Versus Technology Announces Third Quarter Results
11. Replidyne Announces Restructuring of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Venture Construction ... Classic Tournament held on June 20th at the Woodmont Country Club at 1201 ... Wings, an organization dedicated to helping service members that have been wounded in battle ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: